Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jun 15;195(12):1765-73.
doi: 10.1086/518251. Epub 2007 May 2.

Compartmentalization of hepatitis C virus (HCV) during HCV/HIV coinfection

Affiliations

Compartmentalization of hepatitis C virus (HCV) during HCV/HIV coinfection

Jason T Blackard et al. J Infect Dis. .

Abstract

Extrahepatic replication has important implications for the transmission and treatment of hepatitis C virus (HCV). We analyzed longitudinal HCV diversity in peripheral-blood mononuclear cells (PBMCs) and serum during HCV monoinfection and HCV/HIV coinfection to determine whether distinct amino acid signatures characterized HCV replicating within PBMCs. Analysis of E1-HVR1 sequences demonstrated higher serum genetic distances among HCV/human immunodeficiency virus (HIV)-coinfected persons. Moreover, consensus PBMC sequences were rarely identical to those in the corresponding serum, suggesting divergence in these 2 compartments. Three of 5 HCV/HIV-coinfected participants showed evidence of HCV compartmentalization in PBMCs. Additionally, signature sequence analysis identified PBMC-specific amino acids in all HCV/HIV-coinfected persons. To our knowledge, this is the first study to identify specific amino acids that may distinguish HCV variants replicating in PBMCs. It is provocative to speculate that extrahepatic HCV diversity may be an important determinant of treatment response and thus warrants additional study, particularly during HCV/HIV coinfection.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest: none reported.

Figures

Figure 1
Figure 1
Phylogenetic tree of consensus E1-HVR1 amino acid sequences from serum (black symbols) and peripheral-blood mononuclear cell (PBMC; white symbols) compartments at visits A (circles), B (squares), and C (triangles). Database reference sequences are indicated by their genotype. Arrow 1 indicates a time point at which the consensus amino acid sequences from the serum and PBMC compartments are identical for patient 48 (hepatitis C virus [HCV]/HIV coinfected). Arrow 2 indicates 2 time points at which the consequence amino acid sequences in the PBMC compartment are identical for patient 30 (HCV/HIV coinfected). *HCV/HIV-coinfected individuals.
Figure 2
Figure 2
Phylogenetic tree analysis of quasispecies E1-HVR1 amino acid sequences from the serum (black circles) and peripheral-blood mononuclear cell (PBMC; white circles) compartments of hepatitis C virus (HCV)/HIV–coinfected women. Relevant bootstrap values >70 (of 100) are shown for PBMC-specific viral variants (highlighted by large, open circles). HCV genotype 2 was used as the reference sequence.
Figure 2
Figure 2
Phylogenetic tree analysis of quasispecies E1-HVR1 amino acid sequences from the serum (black circles) and peripheral-blood mononuclear cell (PBMC; white circles) compartments of hepatitis C virus (HCV)/HIV–coinfected women. Relevant bootstrap values >70 (of 100) are shown for PBMC-specific viral variants (highlighted by large, open circles). HCV genotype 2 was used as the reference sequence.
Figure 3
Figure 3
Signature sequence analysis. Amino acid positions at which the peripheral-blood mononuclear cell (PBMC) and serum clonal distributions are significantly different at a threshold of 70% are underlined. “S30A” and “P30A” indicate, for example, a serum sample and a PBMC sample, respectively, from patient 30 at time point A. Nos. in parentheses indicate the no. of amino acid signatures present in PBMCs at that time point. Shown are the consensus amino acids at each position. In several instances, a given amino acid may appear to be identical between the 2 compartments; however, the frequency distribution of the 10 viral variants that make up that consensus is different between the 2 compartments. The bar highlights the 27 amino acids of HVR1.

Similar articles

Cited by

References

    1. Sherman K, Rouster S, Chung R, Rajicic N. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS clinical trials groups. Clin Infect Dis. 2002;34:831–7. - PubMed
    1. Sulkowski M, Thomas D. Hepatitis C in the HIV-infected person. Ann Intern Med. 2003;138:197–207. - PubMed
    1. Chung R, Andersen J, Volberding P, et al. Peginterferon alpha-2a plus ribavirin versus interferon alpha-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med. 2004;351:451–9. - PMC - PubMed
    1. Perez-Olmeda M, Nunez M, Romero M, et al. Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients. AIDS. 2003;17:1023–8. - PubMed
    1. Torriani F, Rodriguez-Torres M, Rockstroh J, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med. 2004;351:438–50. - PubMed

Publication types

MeSH terms

Associated data